Clinical significance of metabolic syndrome and carotid intima-media thickness in Behҫet’s disease patients: Relation to disease activity

Uyar, 2015, Ann Dermatol, 27, 702, 10.5021/ad.2015.27.6.702 Yalçın, 2013, Prevalence of metabolic syndrome in Behçet disease: a case-control study in Turkey, Am J Clin Dermatol, 14, 421, 10.1007/s40257-013-0034-8 Balta, 2014, Lipid levels in patients with Behcet’s disease, Eur Rev Med Pharmacol Sci, 18, 142 Yazici, 2008, Mortality in Behçet’s syndrome, Clin Exp Rheumatol, 26, S138 Seyahi, 2008, Atherosclerosis in Behçet’s Syndrome, Semin Arthritis Rheum, 38, 1, 10.1016/j.semarthrit.2007.09.009 Abella, 2014, Adipokines, metabolic syndrome and rheumatic diseases, J Immunol Res, 2014, 343746, 10.1155/2014/343746 Gheita, 2014, Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren’s Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome, Mod Rheumatol, 24, 612, 10.3109/14397595.2013.851639 Gheita, 2013, Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness, Z Rheumatol, 72, 172, 10.1007/s00393-012-1058-9 Rizk, 2012, The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis, Int J Rheum Dis, 15, 261, 10.1111/j.1756-185X.2011.01698.x Wong, 2016, The relationship between metabolic syndrome and osteoporosis: a review, Nutrients, 8, 10.3390/nu8060347 Gheita, 2012, Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions, Int J Rheum Dis, 15, 521, 10.1111/1756-185X.12007 Şahin, 2012, Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet’s disease, J Eur Acad Dermatol Venereol, 26, 1498 Musabak, 2005, Lipid profile and anticardiolipin antibodies in Behcet’s disease, Arch Med Res, 36, 387, 10.1016/j.arcmed.2005.03.019 Leiba, 2004, Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease, Ann Rheum Dis, 63, 1445, 10.1136/ard.2003.014241 Kayatas, 2013, Presence of low lipid levels in patients with Behcet’s disease as a protector against atherosclerosis, Eur Rev Med Pharmacol Sci, 17, 2330 Zhang, 2014, Is carotid intima-media thicknessas predictive as other noninvasive techniques for the detection of coronary artery disease?, Arterioscler Thromb Vasc Biol, 34, 1341, 10.1161/ATVBAHA.113.302075 Bauer, 2012, Carotid intima-media thicknessas a biomarker of subclinical atherosclerosis, Swiss Med Wkly., 142, w13705 Keser, 2005, Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet’s disease, Clin Exp Rheumatol, 23, S71 Alan, 2004, Intimamedia thickness and arterial distensibility in Behçet’s disease, Angiology, 55, 413, 10.1177/000331970405500408 Criteria for diagnosis of Behçet’s disease, 1990, International Study Group for Behçet’s Disease, Lancet, 335, 1078 Bhakta, 1999, Behçet’s disease: evaluation of a new instrument to measure clinical activity, Rheumatology (Oxford), 38, 728, 10.1093/rheumatology/38.8.728 National Cholesterol Education Program Expert Panel on Detection, 2001, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Hassan, 2012, Subclinical Atherosclerosis in Behçet’s Disease, Turk J Rheumatol, 27, 109, 10.5606/tjr.2012.016 Messedi, 2011, Atherogenic lipid profile in Behçet’s disease: evidence of alteration of HDL subclasses, Arch Med Res, 42, 211, 10.1016/j.arcmed.2011.05.001 Oğuz, 2016, Behçet’s: a disease or a syndrome? Answer from an expression profiling study, PLoS One, 11, e0149052, 10.1371/journal.pone.0149052 Pandey, 2014, Predictors of coronary artery disease in patients with Behçet’s disease, Cardiology, 129, 203, 10.1159/000365139 Merashli, 2016, Subclinical atherosclerosis in Behcet’s disease: a systematic review and meta-analysis, Semin Arthritis Rheum, 45, 502, 10.1016/j.semarthrit.2015.06.018 Bonitsis, 2015, Gender-specific differences in Adamantiades-Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature, Rheumatology (Oxford), 54, 121, 10.1093/rheumatology/keu247 Messedi, 2011, Intima-media thickness of carotid artery in patients with Behçet’s disease, Arch Med Res, 42, 398, 10.1016/j.arcmed.2011.08.006 Hong, 2008, Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement, Korean J Intern Med, 23, 87, 10.3904/kjim.2008.23.2.87 Oztürk, 2008, Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease, Clin Rheumatol, 27, 961, 10.1007/s10067-007-0825-5 Cure, 2016, Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease, Z Rheumatol Ricart, 2006, Dyslipidaemia in Behcet’s disease as a thrombotic risk factor, Ann Rheum Dis, 65, 1248, 10.1136/ard.2005.049551 Orem, 1999, Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet’s disease, Dermatology, 198, 243, 10.1159/000018122 Kim, 2010, Increased insulin resistance and serum resistin in Korean patients with Behçet’s disease, Arch Med Res, 41, 269, 10.1016/j.arcmed.2010.05.008 Oguz, 2007, Insulin resistance and adiponectin levels in Behçet’s syndrome, Clin Exp Rheumatol, 25, S118 Mauro, 2015, Metabolic syndromeand the immunological affair with the blood-brain barrier, Front Immunol, 5, 677, 10.3389/fimmu.2014.00677 Ozyazgan, 2013, Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet’s disease, Clin Exp Rheumatol, 31, 71